Image

Prospective Evaluation of Complications of MidLine Catheters in the ICU

Prospective Evaluation of Complications of MidLine Catheters in the ICU

Non Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Midline catheters (MCs) are peripheral catheters inserted into a vein in the arm above the elbow crease, with the tip in the axillary vein. As such, they do not enter the central venous circulation and are therefore not considered central venous catheters.

The main complications associated with CM are accidental removal, leakage, subcutaneous diffusion and occlusion. Severe complications include deep vein thrombosis (DVT) and catheter-related bacteremia (CRB). There is very little data on the use of CMs in intensive care units (ICU).

Resuscitation patients are more likely to develop severe catheter-related complications such as deep vein thrombosis and catheter-related infections. While the use of CMs in patients appears to be associated with a low risk of complications, this may not be the case in resuscitation patients.

Investigator therefore proposes to conduct a prospective observational study to determine the frequency and type of complications associated with CMs when they are implanted and used in ICU. In addition, investigator will attempt to determine whether risk factors predictive of complications can be identified. In addition, this study will evaluate whether the use of CMs can reduce the duration of central venous catheter maintenance in the ICU and the risk of central venous catheter-related infections.

Eligibility

Inclusion Criteria:

  • ICU Hospitalization
  • Indication for MidLine catheter placement during the stay

Exclusion Criteria:

  • Minor or protected adult
  • Pregnant woman
  • Local contraindication to the placement of a CM
    • Local infection
    • Venous thrombosis
    • Existing arteriovenous fistula or vascular network to be protected for a fistula for chronic dialysis
    • Paralysis of the limb
  • Need for administration of contraindicated solutions on the peripheral venous route:
    • Catecholamines: Noradrenaline, adrenaline (dose greater than 0.2µg/kg/min)
    • Total parenteral nutrition
    • Glucose solutions at a concentration >20
    • Potassium at a concentration >0.1mEq/ml
    • Vesicants
    • Fluids with pH <5 or >9

Study details
    Catheter Complications

NCT05412108

Centre Hospitalier le Mans

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.